These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26885263)

  • 21. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
    MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
    J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma.
    Mao Y; Chen L; Wang F; Zhu D; Ge X; Hua D; Sun J
    Oncol Lett; 2017 Nov; 14(5):6177-6183. PubMed ID: 29113264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer.
    Sun J; Mao Y; Zhang YQ; Guo YD; Mu CY; Fu FQ; Zhang XG
    Oncol Lett; 2013 Nov; 6(5):1253-1260. PubMed ID: 24179504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder.
    Xu Z; Wang L; Tian J; Man H; Li P; Shan B
    Oncol Lett; 2018 May; 15(5):6519-6526. PubMed ID: 29725402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7-H3 role in the immune landscape of cancer.
    Castellanos JR; Purvis IJ; Labak CM; Guda MR; Tsung AJ; Velpula KK; Asuthkar S
    Am J Clin Exp Immunol; 2017; 6(4):66-75. PubMed ID: 28695059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B7-H3 promotes gastric cancer cell migration and invasion.
    Li Y; Yang X; Wu Y; Zhao K; Ye Z; Zhu J; Xu X; Zhao X; Xing C
    Oncotarget; 2017 Sep; 8(42):71725-71735. PubMed ID: 29069741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway.
    Fan TF; Deng WW; Bu LL; Wu TF; Zhang WF; Sun ZJ
    Am J Transl Res; 2017; 9(3):1369-1380. PubMed ID: 28386362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression.
    Wang F; Wang G; Liu T; Yu G; Zhang G; Luan X
    Cancer Invest; 2014 Jul; 32(6):262-71. PubMed ID: 24787022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis.
    Song J; Shi W; Zhang Y; Sun M; Liang X; Zheng S
    Onco Targets Ther; 2016; 9():6257-6263. PubMed ID: 27785073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-H3 Associates with IMPDH2 and Regulates Cancer Cell Survival.
    Alhamad S; Elmasry Y; Uwagboe I; Chekmeneva E; Sands C; Cooper BW; Camuzeaux S; Salam A; Parsons M
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.
    Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y
    FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity.
    Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X
    Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B7-H3 expression in breast cancer and upregulation of VEGF through gene silence.
    Sun J; Guo YD; Li XN; Zhang YQ; Gu L; Wu PP; Bai GH; Xiao Y
    Onco Targets Ther; 2014; 7():1979-86. PubMed ID: 25378933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7-H3 Immune Checkpoint Protein in Human Cancer.
    Flem-Karlsen K; Fodstad Ø; Nunes-Xavier CE
    Curr Med Chem; 2020; 27(24):4062-4086. PubMed ID: 31099317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
    Pizon M; Schott DS; Pachmann U; Pachmann K
    Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity.
    Feng Y; Xie K; Yin Y; Li B; Pi C; Xu X; Huang T; Zhang J; Wang B; Gu H; Fang J
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
    Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
    J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
    Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
    Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of CYP1B1 and B7-H3 significantly correlates with poor prognosis in colorectal cancer patients.
    Liu X; Wang F; Wu J; Zhang T; Liu F; Mao Y; Hua D
    Int J Clin Exp Pathol; 2018; 11(5):2654-2664. PubMed ID: 31938380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.
    Katayama A; Takahara M; Kishibe K; Nagato T; Kunibe I; Katada A; Hayashi T; Harabuchi Y
    Int J Oncol; 2011 May; 38(5):1219-26. PubMed ID: 21344157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.